Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Health Canada approves Myfembree to manage moderate to severe pain associated with endometriosis – Sumitomo Pharma Canada + Pfizer Canada

Written by | 26 Oct 2023

Sumitomo Pharma Canada, Inc. and Pfizer Canada announced that Health Canada has granted a Notice of Compliance (NOC) for Myfembree (Relugolix, estradiol and norethindrone acetate tablets) for the… read more.

Can cognitive-behavioral therapy lessen fibromyalgia pain?

Written by | 21 Sep 2023

In a recent randomized clinical trial of patients with fibromyalgia, cognitive-behavioral therapy (CBT)—which uses structured techniques to alter distorted thoughts and negative moods—was superior to a matched education… read more.

Inceptiv spinal cord stimulator with closed-loop sensing to treat chronic pain receives CE Mark – Medtronic plc

Written by | 29 Aug 2023

Medtronic plc has received CE (Conformité Européenne) Mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS). It is the first Medtronic SCS device to offer a… read more.

EU approves Aquipta for prophylaxis of migraine – AbbVie

Written by | 23 Aug 2023

AbbVie announced that the European Commission has approved Aquipta (atogepant) for the prophylaxis of migraine in adults who have four or more migraine days per month. The approval… read more.

Oxycodone prescriptions after delivery not linked to longer-term opioid use compared to codeine prescriptions

Written by | 2 Aug 2023

Over the last 10 years, there has been a shift to fewer codeine prescriptions and an increase in prescriptions for stronger opioids, such as hydrocodone, hydromorphone and oxycodone… read more.

Patients with rheumatic and musculoskeletal conditions vulnerable to long term opioid use

Written by | 19 May 2023

Patients with rheumatic and musculoskeletal conditions are vulnerable to long term opioid use, with up to 1 in 3 of those with rheumatoid arthritis or fibromyalgia, who take… read more.

New study questions the efficacy of many osteoarthritis treatments

Written by | 29 Apr 2023

Recruiting osteoarthritis patients with a lot of pain to clinical studies, may give incorrect results if the researcher does account for the natural variation in pain that occurs…. read more.

Vitamin D ineffective for statin-related pain

Written by | 30 Nov 2022

Statin-related pain is not reduced by vitamin D therapy, researchers reported on Nov. 23, 2022 in JAMA Cardiology. As background, the authors noted, “Statin-associated muscle symptoms (SAMS) are… read more.

Pain is no joke in labor, but withdrawing laughing gas has no ill effects

Written by | 19 Sep 2022

Birthing women denied nitrous oxide (‘laughing gas’) to relieve labour pain during the COVID-19 pandemic have turned to opioids instead, without any adverse outcomes for mother or child,… read more.

New study confirms that postoperative pain can be reduced with NOL guided analgesia

Written by | 18 Sep 2022

A new study has found that monitoring pain response levels during surgery with NOL technology (Medasense, Ramat Gan, Israel) can help reduce postoperative pain. Exploring the clinical effect… read more.

Pain management services and the British Pain Society

Written by | 19 Aug 2022

Pain affects people across a wide range of specialties and there is increasing evidence to suggest that medicines might not always be the answer. In this series of… read more.

Getting started in pain services

Written by | 18 Aug 2022

Effective management of chronic pain calls for an holistic approach and could draw on skills developed in the management of other chronic conditions, says Professor Roger Knaggs (Specialist… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.